![patient on dialysis machine](/sites/default/files/styles/x_large/public/2024-11/kidney_dialysis-1200x675.jpg?itok=lvM24i3l)
Unicycive eyes June FDA verdict for hyperphosphataemia drug
The FDA has started a review of Unicycive Therapeutics' drug for hyperphosphataemia in patients with chronic kidney disease (CKD) who need dialysis, which hopes to improve on 'onerous' phos